A Single-arm Trial of Atezolizumab/Platinum/Etoposide for the Treatment of Advanced Large-cell Neuroendocrine Cancer of the Lung
Clinical trial NCT05470595 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05470595
- Sponsor
- Technische Universität Dresden
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-18
- Primary completion
- 2028-01-31
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.